German Chemical Industry Sees Weak Close to 2014

Business was weak for the German chemical industry in the final quarter of 2014, industry association Verband der Chemischen Industrie (VCI) said in its latest quarterly report. Between October and December, Germany's third largest industrial segment saw production, prices, sales and capacity utilization fall back against the previous three month period.

While the German economy continued to grow in late 2014, the chemical industry failed to benefit, as customers curbed ordering in anticipation of a further decline in selling prices, the association explained.

Output in the fourth quarter was down 0.3% against the third quarter. The year-on-year comparison saw a decline of 0.8%. Capacity utilization fell slightly to 83.3% percent but remained within the normal range.

Quarterly sales eased off slightly, by 0.4% against the previous quarter and 0.2% against the 2013 quarter, due to falling prices and lower demand. Both in the quarter-on-quarter and year-on-year comparisons, VCI said, chemical prices declined "markedly," by 0.9%. This ended a nine-month period of stable pricing.

For full year 2015 the industry association expects output to rise by 1.5% against 2014. However, as prices are expected to be around 2% lower than in 2014, sales are forecast to fall 0.5% to €192.2 billion.

Explaining the outlook, VCI general manager Utz Tillmann said the chemicals economy should continue improving over the coming months. Against this backdrop, the industry's companies expect moderate business growth in their major sales markets. At the same time, Tillman said, the low oil price and the weak euro will give impetus to the economy.

On the whole, the association manager added, the German chemical industry's economic dynamics will remain slack.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.